154 related articles for article (PubMed ID: 20599264)
1. The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics.
Luzzatto L
Lancet; 2010 Aug; 376(9742):739-41. PubMed ID: 20599264
[No Abstract] [Full Text] [Related]
2. Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone.
Pamba A; Richardson ND; Carter N; Duparc S; Premji Z; Tiono AB; Luzzatto L
Blood; 2012 Nov; 120(20):4123-33. PubMed ID: 22993389
[TBL] [Abstract][Full Text] [Related]
3. Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria.
Winstanley P
Trop Med Int Health; 2001 Nov; 6(11):952-4. PubMed ID: 11703851
[TBL] [Abstract][Full Text] [Related]
4. The antimalarial and hemolytic properties of 4,4-diaminodiphenyl sulfone (DDS).
Powell RD; DeGowin RL; Eppes RB; McNamara JV; Carson PE
Int J Lepr Other Mycobact Dis; 1967; 35(4):590-604. PubMed ID: 4869693
[No Abstract] [Full Text] [Related]
5. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
[TBL] [Abstract][Full Text] [Related]
6. The development of Lapdap, an affordable new treatment for malaria.
Lang T; Greenwood B
Lancet Infect Dis; 2003 Mar; 3(3):162-8. PubMed ID: 12614733
[TBL] [Abstract][Full Text] [Related]
7. Malaria chemoprophylaxis using proguanil/dapsone combinations on the Thai-Cambodian border.
Shanks GD; Edstein MD; Suriyamongkol V; Timsaad S; Webster HK
Am J Trop Med Hyg; 1992 Jun; 46(6):643-8. PubMed ID: 1621888
[TBL] [Abstract][Full Text] [Related]
8. Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria.
Van Malderen C; Van Geertruyden JP; Machevo S; González R; Bassat Q; Talisuna A; Yeka A; Nabasumba C; Piola P; Daniel A; Turyakira E; Forret P; Van Overmeir C; van Loen H; Robert A; D' Alessandro U
Malar J; 2012 Jul; 11():139. PubMed ID: 22546009
[TBL] [Abstract][Full Text] [Related]
9. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W
Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058
[TBL] [Abstract][Full Text] [Related]
10. Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial.
Alloueche A; Bailey W; Barton S; Bwika J; Chimpeni P; Falade CO; Fehintola FA; Horton J; Jaffar S; Kanyok T; Kremsner PG; Kublin JG; Lang T; Missinou MA; Mkandala C; Oduola AM; Premji Z; Robertson L; Sowunmi A; Ward SA; Winstanley PA
Lancet; 2004 Jun; 363(9424):1843-8. PubMed ID: 15183620
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of Lapudrine (chlorproguanil) and Maloprim (pyrimethamine and dapsone) as chemoprophylactics against malaria in Gambian children.
Greenwood BM; Greenwood AM; Smith AW; Menon A; Bradley AK; Snow RW; Sisay F; Bennett S; Watkins WM; N'Jie AB
Trans R Soc Trop Med Hyg; 1989; 83(2):182-8. PubMed ID: 2692227
[TBL] [Abstract][Full Text] [Related]
12. Chlorproguanil-dapsone for malaria in Africa.
Looareesuwan S; Imwong M; Wilairatana P
Lancet; 2004 Jun; 363(9424):1838-9. PubMed ID: 15183616
[No Abstract] [Full Text] [Related]
13. Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
Krudsood S; Imwong M; Wilairatana P; Pukrittayakamee S; Nonprasert A; Snounou G; White NJ; Looareesuwan S
Trans R Soc Trop Med Hyg; 2005 Feb; 99(2):142-9. PubMed ID: 15607340
[TBL] [Abstract][Full Text] [Related]
14. Erythema multiforme and Malarone(®).
Becher G; Wylie G
Travel Med Infect Dis; 2012 Sep; 10(5-6):279-80. PubMed ID: 22951669
[No Abstract] [Full Text] [Related]
15. Chlorproguanil-dapsone for malaria.
Standing JF; Wong IC
Lancet; 2004 Nov 13-19; 364(9447):1752-3; author reply 1753. PubMed ID: 15541439
[No Abstract] [Full Text] [Related]
16. Atovaquone and proguanil hydrochloride for treatment of malaria.
Kremsner PG; Looareesuwan S; Chulay JD
J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
[TBL] [Abstract][Full Text] [Related]
17. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
[TBL] [Abstract][Full Text] [Related]
18. Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand.
Wilairatana P; Kyle DE; Looareesuwan S; Chinwongprom K; Amradee S; White NJ; Watkins WM
Ann Trop Med Parasitol; 1997 Mar; 91(2):125-32. PubMed ID: 9307653
[TBL] [Abstract][Full Text] [Related]
19. The activity of PS-15 in combination with sulfamethoxazole.
Yeo AE; Rieckmann KH
Trop Med Parasitol; 1994 Jun; 45(2):136-7. PubMed ID: 7939165
[TBL] [Abstract][Full Text] [Related]
20. Drug company to offer new malaria drug cheaply in Africa.
Pincock S
BMJ; 2003 Aug; 327(7411):360. PubMed ID: 12919982
[No Abstract] [Full Text] [Related]
[Next] [New Search]
